Desipramine hydroxylation: variability and effect of antipsychotic drugs

Clin Pharmacol Ther. 1983 Mar;33(3):322-8. doi: 10.1038/clpt.1983.40.

Abstract

Steady-state plasma concentrations of desipramine (DMI), unconjugated 2-OH DMI, and total 2-OH DMI were measured in 82 depressed inpatients, 35 of whom were concurrently receiving a phenothiazine or butyrophenone antipsychotic drug. In the patients not on an antipsychotic, the ratio of unconjugated metabolite to parent varied from 0.01 to 1.5, with a median of 0.48, and was inversely related to the parent drug level. Antipsychotic drug was associated with higher DMI levels and a lower proportion of OH-metabolite (median, 0.23). In both groups the unconjugated form accounted for only about 10% of the total metabolite. No relationship of age, sex, drinking history, or smoking to DMI or 2-OH DMI levels was found.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / pharmacology*
  • Chromatography, Gas
  • Chromatography, High Pressure Liquid
  • Desipramine / analogs & derivatives
  • Desipramine / blood
  • Desipramine / metabolism*
  • Drug Interactions
  • Female
  • Humans
  • Hydroxylation
  • Male
  • Middle Aged
  • Perphenazine / pharmacology

Substances

  • Antipsychotic Agents
  • Perphenazine
  • Desipramine
  • 2-hydroxydesipramine